Lindsay Mitchell

910 total citations
17 papers, 547 citations indexed

About

Lindsay Mitchell is a scholar working on Immunology, Hematology and Nephrology. According to data from OpenAlex, Lindsay Mitchell has authored 17 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 8 papers in Hematology and 7 papers in Nephrology. Recurrent topics in Lindsay Mitchell's work include Complement system in diseases (15 papers), Renal Diseases and Glomerulopathies (7 papers) and Blood groups and transfusion (6 papers). Lindsay Mitchell is often cited by papers focused on Complement system in diseases (15 papers), Renal Diseases and Glomerulopathies (7 papers) and Blood groups and transfusion (6 papers). Lindsay Mitchell collaborates with scholars based in United Kingdom, France and United States. Lindsay Mitchell's co-authors include Louise Arnold, Stephen J. Richards, Peter Hillmen, Anita Hill, Matthew Cullen, Richard Kelly, Walter M. Gregory, D. Cohen, Austin Kulasekararaj and Richard A. Wells and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Lindsay Mitchell

14 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lindsay Mitchell United Kingdom 9 507 320 237 164 109 17 547
Emilio Ojeda Gutierrez United Kingdom 5 276 0.5× 174 0.5× 105 0.4× 94 0.6× 66 0.6× 5 330
Luana Marano Italy 8 237 0.5× 138 0.4× 161 0.7× 95 0.6× 47 0.4× 14 330
Lily Wong Lee Lee Malaysia 2 224 0.4× 133 0.4× 86 0.4× 83 0.5× 51 0.5× 3 266
Ferras Alashkar Germany 10 125 0.2× 76 0.2× 98 0.4× 70 0.4× 23 0.2× 27 237
Peter Rintels United States 9 194 0.4× 64 0.2× 174 0.7× 57 0.3× 8 0.1× 16 335
J. Y. Muller France 11 102 0.2× 49 0.2× 165 0.7× 36 0.2× 7 0.1× 17 252
Francisco Salcido-Ochoa Singapore 6 221 0.4× 20 0.1× 26 0.1× 5 0.0× 14 0.1× 8 323
Marieta Chan Singapore 7 193 0.4× 53 0.2× 74 0.3× 8 0.0× 1 0.0× 17 372
Marie Tamagne France 8 78 0.2× 6 0.0× 125 0.5× 68 0.4× 8 0.1× 15 243
Elena Boyakova Russia 7 163 0.3× 14 0.0× 185 0.8× 12 0.1× 7 0.1× 14 275

Countries citing papers authored by Lindsay Mitchell

Since Specialization
Citations

This map shows the geographic impact of Lindsay Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindsay Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindsay Mitchell more than expected).

Fields of papers citing papers by Lindsay Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindsay Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindsay Mitchell. The network helps show where Lindsay Mitchell may publish in the future.

Co-authorship network of co-authors of Lindsay Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Lindsay Mitchell. A scholar is included among the top collaborators of Lindsay Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lindsay Mitchell. Lindsay Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Griffin, Morag, Richard Kelly, Petra Muus, et al.. (2024). Real‐world experience of pegcetacoplan in paroxysmal nocturnal hemoglobinuria. American Journal of Hematology. 99(5). 816–823. 17 indexed citations
3.
Kelly, Richard, Matthew T. Holt, Jennifer Vidler, et al.. (2023). Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuria. Blood. 143(12). 1157–1166. 21 indexed citations
4.
Kelly, Richard J., Matthew T. Holt, Jennifer Vidler, et al.. (2022). Treatment Outcomes of Complement Protein C5 Inhibition in 509 Patients with Paroxysmal Nocturnal Hemoglobinuria in the United Kingdom. Blood. 140(Supplement 1). 5792–5794.
6.
Peipert, John Devin, Austin Kulasekararaj, Anna Gayà, et al.. (2020). Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria. PLoS ONE. 15(9). e0237497–e0237497. 34 indexed citations
7.
Kulasekararaj, Austin, Anita Hill, Saskia Langemeijer, et al.. (2020). One‐year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab. European Journal Of Haematology. 106(3). 389–397. 30 indexed citations
8.
Richards, Stephen J., Matthew Cullen, Morag Griffin, et al.. (2020). Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI‐deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry. British Journal of Haematology. 189(5). 954–966. 14 indexed citations
9.
Schrezenmeier, Hubert, Austin Kulasekararaj, Lindsay Mitchell, et al.. (2020). One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study. Therapeutic Advances in Hematology. 11. 154257913–154257913. 27 indexed citations
10.
Kulasekararaj, Austin, Anita Hill, Saskia Langemeijer, et al.. (2019). One-Year Efficacy and Safety from a Phase 3 Trial of Ravulizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Receiving Prior Eculizumab Treatment. Blood. 134(Supplement_1). 2231–2231. 5 indexed citations
11.
Richards, Stephen J., Talha Munir, Morag Griffin, et al.. (2017). Extravascular Hemolysis Due to C3-Loading in Patients with PNH Treated with Eculizumab: Defining the Clinical Syndrome. Blood. 130. 3471–3471. 21 indexed citations
12.
Griffin, Morag, Srinivasan Narayanan, Mickey Koh, et al.. (2017). Lessons learned from a review of paroxysmal nocturnal haemoglobinuria (PNH) requests: a report from theUK PNHNetwork. British Journal of Haematology. 182(6). 930–933.
13.
Inverarity, Donald, et al.. (2013). Screening haematology patients for carbapenem-resistant Klebsiella pneumoniae. Journal of Infection Prevention. 15(2). 50–56. 4 indexed citations
14.
Hill, Anita, Richard J. Kelly, Austin Kulasekararaj, et al.. (2012). Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Report of All 153 Patients Treated in the UK. Blood. 120(21). 3472–3472. 13 indexed citations
15.
16.
Kelly, Richard, Anita Hill, Louise Arnold, et al.. (2011). Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood. 117(25). 6786–6792. 347 indexed citations
17.
Kelly, Richard, Anita Hill, Lindsay Mitchell, et al.. (2010). Long Term Treatment with Eculizumab In Paroxysmal Nocturnal Hemoglobinuria (PNH): Sustained Efficacy and Improved Survival. Blood. 116(21). 639–639. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026